Keyphrases
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
100%
Pediatric Acute Lymphoblastic Leukemia
100%
Tumor Suppression
100%
CDKN2B
100%
MiR-497
100%
MicroRNA-497
100%
Leukemia Cells
33%
Engraftment
33%
High-level Expression
22%
BCP-ALL
22%
Overexpression
22%
Patient-derived
22%
MicroRNA
22%
Low Expression
22%
Early Relapse
22%
Cell Cycle Regulators
22%
Therapeutic Target
11%
Cyclin-dependent Kinase 4 (CDK4)
11%
Leukemia
11%
Paediatric B-cell Precursor Acute Lymphoblastic Leukaemia
11%
Patient-derived Xenograft
11%
Excellent Outcome
11%
Molecular Profile
11%
Patient Samples
11%
Cell Growth
11%
Prognostic Factors
11%
Cellular Profile
11%
Leukemia Progression
11%
Relapse-free Survival
11%
Cell Cycle Regulation
11%
Hereafter
11%
Favorable Outcome
11%
Patient Outcomes
11%
In Vivo Growth
11%
Recipient Survival
11%
SCID Mice
11%
G1-S Transition
11%
Cyclin D3
11%
Full Sequences
11%
Key Cells
11%
Epigenetic Repression
11%
Medicine and Dentistry
Neoplasm
100%
Pediatrics
100%
Acute Lymphoblastic Leukemia
100%
microRNA
100%
B Cell
75%
Precursor
75%
Leukemia Cell
75%
Engraftment
75%
Cell Cycle
50%
Leukemia
25%
Prognostic Factor
25%
Xenograft
25%
Cell Cycle Regulation
25%
Recurrence Free Survival
25%
Cell Growth
25%
Cyclin-Dependent Kinase 4
25%
Epigenetic Repression
25%
SCID Mouse
25%
Cyclin D3
25%
G1/S Transition
25%
Biochemistry, Genetics and Molecular Biology
B Cell
100%
Precursor
100%
MicroRNA
100%
CDKN2B
100%
Cell Cycle
66%
Cell Growth
33%
Cell Cycle Regulation
33%
Recurrence Free Survival
33%
Cyclin-Dependent Kinase 4
33%
Epigenetic Repression
33%
Cyclin D3
33%
NOD SCID Mouse
33%
G1/S Transition
33%
Immunology and Microbiology
Precursor
100%
B Cell
100%
Leukemia Cell
100%
Engraftment
100%
Cell Cycle
66%
Cell Growth
33%
Xenograft
33%
Cell Cycle Regulation
33%
Recurrence Free Survival
33%
Cycline
33%
NOD SCID Mouse
33%
Cyclin D3
33%
Epigenetic Repression
33%